T cell activation and immune function are regulated by the innate immune system through positive and negative costimulatory molecules. CD276, also known B7-homolog 3 (B7-H3) belongs to the B7 immunoglobulin superfamily. Soluble CD276 binds a putative receptor on activated T-cells that is distinct from CD28, CTLA-4, ICOS and PD-1. Widely expressed on nonlymphoid tissues, CD276 costimulates proliferation of both CD4+ and CD8+ T cells. The ability of CD276 to stimulate Th1 and cytotoxic-T cell responses suggest that it may have antitumor activity. CD276 interactions may play a role in regulating cell-mediated immune responses against cancer, implicating CD276 as a potential therapeutic tool.
Clone
MD235
Isotype
IgG1k
Host species
Mouse
Species Reactivity
Human
Cellular Localization
Membrane, cytoplasm
Positive Control
Tonsil, placenta, HCC, lung carcinoma, breast cancer
Applications
IHC
Intended Use
Research Use Only